−135KRW
−4.52 BKRW
169.57 BKRW
24.45 M
About MYUNGMOON PHARM
Sector
CEO
Choon-Sik Park
Headquarters
Hwaseong-si
Website
Employees (FY)
291
Founded
1983
ISIN
KR7017180001
FIGI
BBG000BK7P09
MYUNGMOON Pharm Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include ethical drugs (ETC), over-the-counter drugs (OTC), and indication drugs. The ethical drugs include anesthetic agent, analgesic agent, anti-epileptics, anti-depressants, anti-diabetics, anti-osteoporosis, and others. The over-the-counter drugs provide medicines for eye nutrition, colds, parasiticide, cathartic, muscle relaxant, hepatics, and others. The company was founded on September 1, 1983 and is headquartered in Hwaseong, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 017180 is 2040 KRW — it has decreased by 1.69% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange MYUNGMOON PHARM stocks are traded under the ticker 017180.
017180 stock is 2.22% volatile and has beta coefficient of 0.61. Check out the list of the most volatile stocks — is MYUNGMOON PHARM there?
Yes, you can track MYUNGMOON PHARM financials in yearly and quarterly reports right on TradingView.
017180 stock has fallen by 1.21% compared to the previous week, the month change is a 8.52% fall, over the last year MYUNGMOON PHARM has showed a 19.05% decrease.
017180 net income for the last quarter is −4.03 B KRW, while the quarter before that showed −938.90 M KRW of net income which accounts for −329.41% change. Track more MYUNGMOON PHARM financial stats to get the full picture.
Today MYUNGMOON PHARM has the market capitalization of 69.57 B, it has decreased by 0.73% over the last week.
Like other stocks, 017180 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYUNGMOON PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 291.00 employees. See our rating of the largest employees — is MYUNGMOON PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYUNGMOON PHARM technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYUNGMOON PHARM stock shows the sell signal. See more of MYUNGMOON PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MYUNGMOON PHARM EBITDA is 4.92 B KRW, and current EBITDA margin is 2.67%. See more stats in MYUNGMOON PHARM financial statements.